Nasal Packing Sterility
While the American Academy of Otolaryngology-Head and Neck Surgery guidelines do not explicitly mandate sterile nasal packing, the evidence strongly supports using sterile technique and materials to minimize infectious complications, particularly toxic shock syndrome and biofilm formation.
Infection Risk and Sterility Considerations
The primary concern with nasal packing relates to bacterial colonization and infection risk:
Nasal packing acts as a foreign material that can support bacterial growth, with specific risk of infection spreading to the nose, sinuses, or in rare cases systemically 1.
Toxic shock syndrome, though rare, is a potentially fatal complication associated with nasal packing and ineffective sterile techniques 2. This multisystem disease typically develops within the first 48 hours postoperatively and is associated with Staphylococcus aureus colonization.
Bacterial biofilm formation occurs more readily when nasal wounds are combined with nasal packing and pathogenic bacteria presence 3. Research demonstrates that nasal wounds, packing, and bacteria are all essential elements for biofilm formation, which can lead to recalcitrant infections.
Practical Recommendations
Sterile Technique Application
Use sterile packing materials and maintain sterile technique during insertion to minimize bacterial inoculation 2.
Packs are often impregnated with antibiotic ointments prior to insertion as an additional infection prevention measure 1.
Antibiotic Prophylaxis Considerations
The use of systemic antibiotic prophylaxis while nasal packs are in place remains controversial 1.
Systemic antibiotics directed against Staphylococcus aureus are often used, though systematic reviews have not shown significant benefit for routine use 1.
The risks and benefits of antibiotic use should be evaluated for each patient, particularly considering that individual studies were underpowered to detect rare complications like toxic shock syndrome 1.
Duration Minimization
Keep packing duration as short as clinically necessary, typically 48-72 hours, with maximum duration of 5 days for non-resorbable packing 1.
Shorter packing duration reduces biofilm formation risk and other complications 3.
Common Pitfalls to Avoid
Do not use non-sterile materials or contaminated packing, as this directly increases infection risk including toxic shock syndrome 2.
Avoid prolonged packing duration beyond what is clinically necessary, as this increases risks of infection, mucosal injury, and biofilm formation 1, 3.
Monitor patients for warning signs including fever >101°F, increasing pain, vision changes, facial swelling, or diffuse skin rash, which warrant immediate reassessment 1.